Kristi Elkins

Statistics

Publications

Citations

1.2K

H-Index

Active since

2007

Affiliations

Leeds Teaching Hospitals NHS Trust(Current)

University of York

Hull York Medical School

Kristi Elkins is an author at Leeds Teaching Hospitals NHS Trust specializing in oncology, antibody-drug conjugate therapy, and antibody-drug conjugates.

Publications per year

2007–2022

Publications

Therapeutic potential of an anti-CD79b antibody–drug conjugate, anti–CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma

David Dornan, Fiona Bennett, Yvonne Chen et al. · Blood · 2009 · 271 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection

Andrew G. Polson, Jill Calemine-Fenaux, Pamela Chan et al. · Cancer Research · 2009 · 249 citations

Medicine, Oncology, Pharmacology +17

Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma

Andrew G. Polson, Shang‐Fan Yu, Kristi Elkins et al. · Blood · 2007 · 172 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

FcRL5 as a Target of Antibody–Drug Conjugates for the Treatment of Multiple Myeloma

Kristi Elkins, Bing Zheng, MaryAnn Go et al. · Molecular Cancer Therapeutics · 2012 · 88 citations

Pharmacy, Immunology, Pharmacology +17

DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma

Dongwei Li, Kirsten Achilles Poon, Shang‐Fan Yu et al. · Molecular Cancer Therapeutics · 2013 · 85 citations

Pharmacy, Oncology, Pharmacokinetics +17

1–5 of 11